Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathryn Howells"'
Autor:
John V. Heymach, Jack J. Lee, Ignacio I. Wistuba, Robert R. Langley, Jing Wang, Roy S. Herbst, Juliane M. Jüergensmeier, Anderson J. Ryan, Ju-Seog Lee, Weiyi Peng, Yun-Yong Park, Babita Saigal, Humam Kadara, Uma Giri, Maria A. Cortez, Monique B. Nilsson, Emer Hanrahan, Vincent Haddad, Kathryn Howells, Yuan Liu, Hai T. Tran, Wenbin Liu, Heather Y. Lin, Li Xu, Tina Cascone
Purpose: Resistance to VEGFR inhibitors is a major obstacle in the treatment of non–small cell lung cancer (NSCLC). We investigated the cellular mechanisms mediating resistance of NSCLCs to VEGFR tyrosine kinase inhibitors.Experimental Design: We g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9d4357a9de17f355074b3ee560e130
https://doi.org/10.1158/1078-0432.c.6526973
https://doi.org/10.1158/1078-0432.c.6526973
Autor:
John V. Heymach, Jack J. Lee, Ignacio I. Wistuba, Robert R. Langley, Jing Wang, Roy S. Herbst, Juliane M. Jüergensmeier, Anderson J. Ryan, Ju-Seog Lee, Weiyi Peng, Yun-Yong Park, Babita Saigal, Humam Kadara, Uma Giri, Maria A. Cortez, Monique B. Nilsson, Emer Hanrahan, Vincent Haddad, Kathryn Howells, Yuan Liu, Hai T. Tran, Wenbin Liu, Heather Y. Lin, Li Xu, Tina Cascone
Supplemental Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99985c042e4089f9a187422ad620448a
https://doi.org/10.1158/1078-0432.22468499.v1
https://doi.org/10.1158/1078-0432.22468499.v1
Autor:
Bradley Monk, Takafumi Toita, Xiaohua Wu, Juan Carlos Limón, Qi Zhou, Rafal Tarnawski, Masaki Mandai, Ronnie Shapira-Frommer, Umesh Mahantshetty, Maria Del Pilar Estevez-Diz, Francisco Ramirez Godinez, Szilvia Varga, Manuel Humberto Leiva Gálvez, Jung-Yun Lee, Yulia Kreynina, Kathryn Howells, Sophie Wildsmith, Hannah Dry, Ana Nunes, Jyoti Mayadev
Publikováno v:
Oral Abstracts (Regular and Late-Breaking Submission).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f720f49122c4f2f12e6c00f1d5dee572
https://doi.org/10.1136/ijgc-2022-igcs.3
https://doi.org/10.1136/ijgc-2022-igcs.3
Autor:
Jonathan E. Rosenberg, Se Hoon Park, Tu V. Dao, Daniel E. Castellano, Jian-Ri Li, Som Mukherjee, Kathryn Howells, Hannah Dry, Mark C. Lanasa, Ross Stewart, Dean F. Bajorin
Publikováno v:
Journal of Clinical Oncology. 40:437-437
437 Background: The prognosis for patients (pts) with advanced UC remains poor, particularly for those unable to tolerate platinum-based chemotherapy. Defects in DNA damage repair (e.g., mutations in homologous recombination repair [HRR] genes) are c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19009f2790938bdcb80c6a7e6c24a094
https://doi.org/10.1200/jco.2022.40.6_suppl.437
https://doi.org/10.1200/jco.2022.40.6_suppl.437